Erratum to: Lee AW, Ng WT, Pan JJ, et al. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2019;105:567-580.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Dec 01; Vol. 105 (5), pp. 1166-1167.

Application of Artificial Intelligence for Nasopharyngeal Carcinoma Management – A Systematic Review

Autor: Ng WT, But B, Choi HCW, de Bree R, Lee AWM, Lee VHF, López F, Mäkitie AA, Rodrigo JP, Saba NF, Tsang RKY, Ferlito A

Publikováno v: Cancer Management and Research, Vol Volume 14, Pp 339-366 (2022)

Wai Tong Ng,1,2 Barton But,2 Horace CW Choi,3 Remco de Bree,4 Anne WM Lee,1,2 Victor HF Lee,1,2 Fernando López,5,6 Antti A Mäkitie,7– 9 Juan P Rodrigo,5,6 Nabil F Saba,10 Raymond KY Tsang,11 Alfio Ferlito12 1Clinical Oncology Center, The Universi

Externí odkaz: https://doaj.org/article/d6f03d2989044769ab2cf3d8ac59d9fd

Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification.

Autor: Pan JJ; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China.; Xiamen Humanity Hospital, Fujian Medical University Fujian, China.; American Joint Committee on Cancer Expert Panel., Mai HQ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Ng WT; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Hu CS; Fudan University Shanghai Cancer Center, Shanghai, China., Li JG; Jiangxi Cancer Hospital and NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang Medical College), Jiangxi, China., Chen XZ; Zhejiang Cancer Hospital, Zhejiang, China., Chow JCH; Queen Elizabeth Hospital, Hong Kong, China., Wong E; Pamela Youde Nethersole Eastern Hospital, Hong Kong, China., Lee V; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; The University of Hong Kong, China., Ma LY; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Guo QJ; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China., Liu Q; The University of Hong Kong, China., Liu LZ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Xu TT; Fudan University Shanghai Cancer Center, Shanghai, China., Gong XC; Jiangxi Cancer Hospital and NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang Medical College), Jiangxi, China., Qiang MY; Zhejiang Cancer Hospital, Zhejiang, China., Au KH; Queen Elizabeth Hospital, Hong Kong, China., Liu TC; Pamela Youde Nethersole Eastern Hospital, Hong Kong, China., Chiang CL; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; The University of Hong Kong, China., Xiao YP; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China., Lin SJ; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China., Chen YB; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China., Guo SS; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Wong CHL; The University of Hong Kong, China., Tang LQ; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Xu ZY; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Jia YZ; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Peng WS; Fudan University Shanghai Cancer Center, Shanghai, China., Hu LP; Jiangxi Cancer Hospital and NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang Medical College), Jiangxi, China., Lu TZ; Jiangxi Cancer Hospital and NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang Medical College), Jiangxi, China., Jiang F; Zhejiang Cancer Hospital, Zhejiang, China., Cao CN; Zhejiang Cancer Hospital, Zhejiang, China., Xu W; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Ma J; American Joint Committee on Cancer Expert Panel.; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China., Blanchard P; American Joint Committee on Cancer Expert Panel.; Union for International Cancer Control Head and Neck Core Group.; Department of Radiation Oncology, Université Paris-Saclay, INSERM U1018 Oncostat, Gustave-Roussy, Villejuif, France., Williams M; American Joint Committee on Cancer Expert Panel., Glastonbury CM; American Joint Committee on Cancer Expert Panel., King AD; American Joint Committee on Cancer Expert Panel.; The Chinese University of Hong Kong, China., Patel SG; American Joint Committee on Cancer Head and Neck Core Group.; Memorial Sloan Kettering Cancer Center, New York, New York., Seethala RR; American Joint Committee on Cancer Head and Neck Core Group.; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Colevas AD; American Joint Committee on Cancer Expert Panel.; Stanford University School of Medicine, Stanford, California., Fan DM; China Anti-Cancer Association., Chua MLK; American Joint Committee on Cancer Expert Panel.; Union for International Cancer Control Head and Neck Core Group.; National Cancer Centre Singapore and Duke-NUS Medical School, Singapore., Huang SH; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Union for International Cancer Control Head and Neck Core Group.; American Joint Committee on Cancer Head and Neck Core Group., O'Sullivan B; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Union for International Cancer Control Head and Neck Core Group.; American Joint Committee on Cancer Head and Neck Core Group., Lydiatt W; American Joint Committee on Cancer Head and Neck Core Group.; Nebraska Methodist Health System, Omaha, Nebraska., Lee AWM; American Joint Committee on Cancer Expert Panel.; The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; Union for International Cancer Control Head and Neck Core Group.

Publikováno v: JAMA oncology [JAMA Oncol] 2024 Oct 10. Date of Electronic Publication: 2024 Oct 10.

Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer.

Autor: Chiang CL; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China. Electronic address: chiangcl@hku.hk., Chan KSK; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Li H; School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Ng WT; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Chow JCH; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China., Choi HCW; School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Lam KO; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Lee VHF; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Ngan RKC; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, Hong Kong, China., Lee AWM; Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, and University of Hong Kong-Shenzhen Hospital, Hong Kong, China., Eschrich SA; Cvergenx, Inc St Petersburg, FL, United States., Torres-Roca JF; Cvergenx, Inc St Petersburg, FL, United States., Wong JWH; School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China. Electronic address: jwhwong@hku.hk.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jul; Vol. 196, pp. 110287. Date of Electronic Publication: 2024 Apr 16.

Dosimetric parameters predict radiation-induced temporal lobe necrosis in nasopharyngeal carcinoma patients: A systematic review and meta-analysis.

Autor: Dong J; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Ng WT; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China; Department of Clinical Oncology, Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Electronic address: ngwt1@hku.hk., Wong CHL; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Li JS; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Bollen H; Laboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven, Belgium; Department of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, Belgium., Chow JCH; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China., Eisbruch A; Department of Radiation Oncology, University of Michigan Medicine, Ann Arbor, MI, USA., Lee AWM; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China; Department of Clinical Oncology, Shenzhen Key Laboratory for Cancer Metastasis and Personalized Therapy, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Lee VHF; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China., Ng SP; Department of Radiation Oncology, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Melbourne, Australia., Nuyts S; Laboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven, Belgium; Department of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, Belgium., Smee R; Department of Radiation Oncology, The Prince of Wales Cancer Centre, Sydney, Australia., Ferlito A; Coordinator of the International Head and Neck Scientific Group, Padua, Italy.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jun; Vol. 195, pp. 110258. Date of Electronic Publication: 2024 Mar 26.